-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FeowbLsYtosKrStSeGCr8ljSw7S7f7S2cTMmUmXKIDZpWlIUkIImYVzWL0cD946E j7WNUJk7OFuAY3P4yFZKGA== 0001434913-09-000003.txt : 20091014 0001434913-09-000003.hdr.sgml : 20091014 20091014163011 ACCESSION NUMBER: 0001434913-09-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091014 DATE AS OF CHANGE: 20091014 EFFECTIVENESS DATE: 20091014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACT BIOTECH INC CENTRAL INDEX KEY: 0001434913 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-118072 FILM NUMBER: 091119436 BUSINESS ADDRESS: STREET 1: 717 MARKET STREET, SUITE 650 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 230-3901 MAIL ADDRESS: STREET 1: 717 MARKET STREET, SUITE 650 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0603 D LIVE 0001434913 ACT BIOTECH INC 717 MARKET STREET, SUITE 650 SAN FRANCISCO CA 94103 (415) 230-3901 DELAWARE None None Corporation true 2008 Wolf-Dieter Busse c/o ACT Biotech, Inc. 717 Market Street, Suite 650 San Francisco CA 94103 Executive Officer Director Ali Fattaey c/o ACT Biotech, Inc. 717 Market Street, Suite 650 San Francisco CA 94103 Executive Officer John Mahoney c/o ACT Biotech, Inc. 717 Market Street, Suite 650 San Francisco CA 94103 Executive Officer Georg Nebgen 369 Lexington Avenue, 17th Floor New York NY 10017 Director John Costantino 369 Lexington Avenue, 17th Floor New York NY 10017 Director Gary Lazar 20400 Stevens Creek Blvd. Suite 850 Cupertino CA 95014 Director Nils C. Behnke One Embarcadero Center, Suite 3500 San Francisco CA 94111 Director Biotechnology Decline to Disclose 06 false 2009-09-30 false true false 0 500000 500000 0 false 1 0 0 0 Proceeds from the offering will be used for general working capital. false ACT BIOTECH INC /s/ Ali Fattaey Ali Fattaey Chief Financial Officer 2009-10-13 -----END PRIVACY-ENHANCED MESSAGE-----